The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort.
BACKGROUND AND AIMS:Neuromedin U (NMU) is a hypothalamic neuropeptide with important roles in several metabolic processes, recently suggested as potential therapeutic target for obesity. We analysed the associations between NMU gene variants and haplotypes and body mass index (BMI) in a large sample...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5325300?pdf=render |
id |
doaj-e4dfc2abbb824d4789461ddab1a7e900 |
---|---|
record_format |
Article |
spelling |
doaj-e4dfc2abbb824d4789461ddab1a7e9002020-11-25T02:10:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01122e017269810.1371/journal.pone.0172698The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort.Francesco GianfagnaClaudio GrippiWolfgang AhrensMark E S BaileyClaudia BörnhorstStefan De HenauwRonja ForaitaAnna C KoniVittorio KroghStaffan MårildDénes MolnárLuis MorenoYannis PitsiladisPaola RussoAlfonso SianiMichael TornaritisToomas VeidebaumLicia IacovielloBACKGROUND AND AIMS:Neuromedin U (NMU) is a hypothalamic neuropeptide with important roles in several metabolic processes, recently suggested as potential therapeutic target for obesity. We analysed the associations between NMU gene variants and haplotypes and body mass index (BMI) in a large sample of European children. METHODS AND RESULTS:From a large European multi-center study on childhood obesity, 4,528 children (2.0-9.9 years, mean age 6.0±1.8 SD; boys 52.2%) were randomly selected, stratifying by age, sex and country, and genotyped for tag single nucleotide polymorphisms (SNPs; rs6827359, T:C; rs12500837, T:C; rs9999653,C:T) of NMU gene, then haplotypes were inferred. Regression models were applied to estimate the associations between SNPs or haplotypes and BMI as well as other anthropometric measures. BMI was associated with all NMU SNPs (p<0.05). Among five haplotypes inferred, the haplotype carrying the minor alleles (CCT, frequency = 22.3%) was the only associated with lower BMI values (beta = -0.16, 95%CI:-0.28,-0.04, p = 0.006; z-score, beta = -0.08, 95%CI:-0.14,-0.01, p = 0.019) and decreased risk of overweight/obesity (OR = 0.81, 95%CI:0.68,0.97, p = 0.020) when compared to the most prevalent haplotype (codominant model). Similar significant associations were also observed using the same variables collected after two years' time (BMI, beta = -0.25, 95%CI:-0.41,-0.08, p = 0.004; z-score, beta = -0.10, 95%CI:-0.18,-0.03, p = 0.009; overweight/obesity OR = 0.81, 95%CI:0.66,0.99, p = 0.036). The association was age-dependent in girls (interaction between CCT haplotypes and age, p = 0.008), more evident between 7 and 9 years of age. The CCT haplotype was consistently associated with lower levels of fat mass, skinfold thickness, hip and arm circumferences both at T0 and at T1, after adjustment for multiple testing (FDR-adjusted p<0.05). CONCLUSIONS:This study shows an association between a NMU haplotype and anthropometric indices, mainly linked to fat mass, which appears to be age- and sex-specific in children. Genetic variations within or in linkage with this haplotype should be investigated to identify functional variants responsible for the observed phenotypic variation.http://europepmc.org/articles/PMC5325300?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Francesco Gianfagna Claudio Grippi Wolfgang Ahrens Mark E S Bailey Claudia Börnhorst Stefan De Henauw Ronja Foraita Anna C Koni Vittorio Krogh Staffan Mårild Dénes Molnár Luis Moreno Yannis Pitsiladis Paola Russo Alfonso Siani Michael Tornaritis Toomas Veidebaum Licia Iacoviello |
spellingShingle |
Francesco Gianfagna Claudio Grippi Wolfgang Ahrens Mark E S Bailey Claudia Börnhorst Stefan De Henauw Ronja Foraita Anna C Koni Vittorio Krogh Staffan Mårild Dénes Molnár Luis Moreno Yannis Pitsiladis Paola Russo Alfonso Siani Michael Tornaritis Toomas Veidebaum Licia Iacoviello The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. PLoS ONE |
author_facet |
Francesco Gianfagna Claudio Grippi Wolfgang Ahrens Mark E S Bailey Claudia Börnhorst Stefan De Henauw Ronja Foraita Anna C Koni Vittorio Krogh Staffan Mårild Dénes Molnár Luis Moreno Yannis Pitsiladis Paola Russo Alfonso Siani Michael Tornaritis Toomas Veidebaum Licia Iacoviello |
author_sort |
Francesco Gianfagna |
title |
The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. |
title_short |
The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. |
title_full |
The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. |
title_fullStr |
The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. |
title_full_unstemmed |
The role of neuromedin U in adiposity regulation. Haplotype analysis in European children from the IDEFICS Cohort. |
title_sort |
role of neuromedin u in adiposity regulation. haplotype analysis in european children from the idefics cohort. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
BACKGROUND AND AIMS:Neuromedin U (NMU) is a hypothalamic neuropeptide with important roles in several metabolic processes, recently suggested as potential therapeutic target for obesity. We analysed the associations between NMU gene variants and haplotypes and body mass index (BMI) in a large sample of European children. METHODS AND RESULTS:From a large European multi-center study on childhood obesity, 4,528 children (2.0-9.9 years, mean age 6.0±1.8 SD; boys 52.2%) were randomly selected, stratifying by age, sex and country, and genotyped for tag single nucleotide polymorphisms (SNPs; rs6827359, T:C; rs12500837, T:C; rs9999653,C:T) of NMU gene, then haplotypes were inferred. Regression models were applied to estimate the associations between SNPs or haplotypes and BMI as well as other anthropometric measures. BMI was associated with all NMU SNPs (p<0.05). Among five haplotypes inferred, the haplotype carrying the minor alleles (CCT, frequency = 22.3%) was the only associated with lower BMI values (beta = -0.16, 95%CI:-0.28,-0.04, p = 0.006; z-score, beta = -0.08, 95%CI:-0.14,-0.01, p = 0.019) and decreased risk of overweight/obesity (OR = 0.81, 95%CI:0.68,0.97, p = 0.020) when compared to the most prevalent haplotype (codominant model). Similar significant associations were also observed using the same variables collected after two years' time (BMI, beta = -0.25, 95%CI:-0.41,-0.08, p = 0.004; z-score, beta = -0.10, 95%CI:-0.18,-0.03, p = 0.009; overweight/obesity OR = 0.81, 95%CI:0.66,0.99, p = 0.036). The association was age-dependent in girls (interaction between CCT haplotypes and age, p = 0.008), more evident between 7 and 9 years of age. The CCT haplotype was consistently associated with lower levels of fat mass, skinfold thickness, hip and arm circumferences both at T0 and at T1, after adjustment for multiple testing (FDR-adjusted p<0.05). CONCLUSIONS:This study shows an association between a NMU haplotype and anthropometric indices, mainly linked to fat mass, which appears to be age- and sex-specific in children. Genetic variations within or in linkage with this haplotype should be investigated to identify functional variants responsible for the observed phenotypic variation. |
url |
http://europepmc.org/articles/PMC5325300?pdf=render |
work_keys_str_mv |
AT francescogianfagna theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT claudiogrippi theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT wolfgangahrens theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT markesbailey theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT claudiabornhorst theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT stefandehenauw theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT ronjaforaita theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT annackoni theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT vittoriokrogh theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT staffanmarild theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT denesmolnar theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT luismoreno theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT yannispitsiladis theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT paolarusso theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT alfonsosiani theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT michaeltornaritis theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT toomasveidebaum theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT liciaiacoviello theroleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT francescogianfagna roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT claudiogrippi roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT wolfgangahrens roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT markesbailey roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT claudiabornhorst roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT stefandehenauw roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT ronjaforaita roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT annackoni roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT vittoriokrogh roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT staffanmarild roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT denesmolnar roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT luismoreno roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT yannispitsiladis roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT paolarusso roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT alfonsosiani roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT michaeltornaritis roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT toomasveidebaum roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort AT liciaiacoviello roleofneuromedinuinadiposityregulationhaplotypeanalysisineuropeanchildrenfromtheideficscohort |
_version_ |
1724919454279663616 |